Robitussin and Faslodex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robitussin (guaifenesin) and Faslodex (fulvestrant). Common drug interactions include cough among females.

The phase IV clinical study analyzes what interactions people have when they take Robitussin and Faslodex. It is created by eHealthMe based on reports of 8 people who take the same drugs from the FDA, and is updated regularly.

What is Robitussin?

Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.

What is Faslodex?

Faslodex has active ingredients of fulvestrant. It is often used in breast cancer metastatic. eHealthMe is studying from 19,255 Faslodex users. Check the latest studies of Faslodex.



On Jul, 21, 2026

8 people who take Robitussin and Faslodex together, and have interactions are studied.

Robitussin and Faslodex drug interactions.

What are the common drug interactions of Robitussin and Faslodex, by gender? *:

female:

  1. Cough
  2. Blood pressure increased
  3. Alopecia (absence of hair from areas of the body)
  4. Alveolitis (inflammation in the socket of a tooth)
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Anaemia (lack of blood)
  7. Anxiety
  8. Aortic calcification (aortic calcification sign of heart valve disease)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

n/a

What are the common drug interactions of Robitussin and Faslodex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Joint instability (a condition in which the joints aren't sufficiently supported)
  2. Lacunar infarction (a type of stroke)
  3. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  4. Leukodystrophy (degeneration of the white matter in the brain)
  5. Localised oedema (fluid retention in a particular part of the body)
  6. Lumbar radiculopathy (radicular pain in the low back and legs)
  7. Lymph node palpable
  8. Lymphocyte count decreased
  9. Lymphoedema (localized fluid retention and tissue swelling)
  10. Mass

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cough
  2. Arthralgia (joint pain)
  3. Blood pressure increased
  4. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  5. Lymphoedema (localized fluid retention and tissue swelling)
  6. Nail discolouration (change in nail colour)
  7. Neoplasm progression (growth of tumour)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Renal cell carcinoma (a kidney cancer)
  10. Rib fracture

60+:

  1. Blood pressure increased
  2. Bone cancer metastatic
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Metastases to bone (cancer spreads to bone)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Renal cell carcinoma (a kidney cancer)
  9. Rib fracture
  10. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)

* Approximation only. Some reports may have incomplete information.

Do you take Robitussin and Faslodex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Robitussin and Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Robitussin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robitussin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Faslodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin and fulvestrant (the active ingredients of Robitussin and Faslodex, respectively), and Robitussin and Faslodex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: